hengrui glp 1 BMS signs $15.2bn R&D alliance with China's Hengrui blazes trail as Chinese
Description
Men's Fat Loss &
Pfizer is developing a long-acting GLP-1 drug that could compete directly with Eli Lilly's Mounjaro and Zepbound when it reaches the Canadian market.
Suggested Use: Take 1 capsule 3 times daily, ideally before meals, as part of a balanced health routine
A new study explores the interactions between cosmetic Botox and GLP-1 weight loss medications and whether it impacts how long botox results last
